3rd Quarter - Report
BIOCOM for BIOCOM
Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Advocated for increased funding for NIH and FDA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Health Issues HCR
Hosted a congressional briefing on oncology and genomics Advocated for the repeal of IPAB Advocated for the repeal of the medical device tax
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Trade (domestic/foreign) TRD
Advocated for the protection of 12 years of data exclusivities for biologics in NAFTA
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Economics/Economic Development ECN
Discussed Biocom 2017 economic impact report and statewide expansion
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.